Cardiosense company information, Employees & Contact Information

Cardiosense Presents New Clinical Analysis of SEISMIC-HF I Data on AI-Enabled Volume Assessment in Heart Failure at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 Scientific Symposium Business Wire

Cardiosense's CardioTag Device Gets FDA 510(k) Clearance for Advanced Cardiac Function Monitoring Diagnostic and Interventional Cardiology

Cardiosense names Eric Meizlish as CEO MedTech Dive

Cardiosense pairs advanced sensors with AI for its heart failure wearable Medical Design & Outsourcing

Results from Cardiosense's SEISMIC-HF I Study of a Machine Learning Model to Non-Invasively Assess Cardiac Filling Pressure Presented as Late-Breaking Science at American Heart Association's 2024 Scientific Sessions PR Newswire

Cardiosense wins FDA clearance for wearable heart monitor MedTech Dive

Cardiosense Launches Nationwide SEISMIC-HF II Study to Validate Its AI Algorithm for Non-Invasive Heart Failure Management Business Wire

Cardiosense appoints John Martin as chief medical officer MedTech Dive

Cardiosense scores FDA clearance for wearable sensor that monitors heart function Fierce Biotech

Cardiosense names Eric Meizlish as new CEO The Business Journals

Cardiosense hires Dr. John Martin as chief medical officer MassDevice

FDA grants 510(k) clearance for Cardiosense’s wearable sensor Medical Device Network

Cardiosense Presents Interim Clinical Study Data for Machine Learning Algorithm to Aid in Heart Failure Management at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 Scientific Symposium PR Newswire

Cardiosense Announces Publication of SEISMIC-HF I Study Results in the Journal of the American College of Cardiology: Heart Failure Business Wire

Cardiosense wins FDA clearance for wearable sensor MassDevice

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease PR Newswire

Cardiosense Begins Enrollment in Nationwide Heart Failure Study PR Newswire

Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure PR Newswire

Cardiosense names medtech veteran John Martin chief medical officer Medical Economics

FDA clears wearable heart device that captures multiple signals at once Cardiovascular Business

Cardiosense wins FDA Clearance for wearable heart monitor, CardioTag Medical Economics

Cardiosense gets FDA OK for multitasker of a wearable heart sensor Crain's Chicago Business

Cardiosense names new CEO to take AI tools to next growth phase Crain's Chicago Business

Cardiosense Raises $15.1 Million in Series A Funding The SaaS News

Cardiosense eyes 2026 commercial launch after wearable heart monitor gets FDA clearance The Business Journals

Cardiosense Names Eric Meizlish as CEO Medical Product Outsourcing

Exclusive: Cardiosense raises $15M Series A for heart failure tech Axios

Cardiosense lands $15M for AI to predict worsening heart failure from wearables Fierce Biotech

Cardiosense’s $15.1M Raise, TransLoop’s New Office, and More Chicago Tech News Built In Chicago

Heart monitoring startup raises $15 million Crain's Chicago Business